Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Cancer Clinical Trials|January 1, 1979
Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCGJ C Britell, D L Ahmann, H F Bisel, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.
Mayo Clinic Proceedings|June 1, 1993
Role of radiation therapy in the management of lung cancerE G Shaw, J A Bonner, R L Foote, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Cancer|June 1, 1979
A phase I study of chlorozotocin (NSC 178248)J S Kovach, C G Moertel, A J Schutt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Cancer Treatment Reports|October 1, 1980
Phase II evaluation of triazinate in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|November 1, 1981
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1979
Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lungR T Eagan, R E Lee, S Frytak, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Cancer Clinical Trials|January 1, 1979
Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCGJ C Britell, D L Ahmann, H F Bisel, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.
Mayo Clinic Proceedings|June 1, 1993
Role of radiation therapy in the management of lung cancerE G Shaw, J A Bonner, R L Foote, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Cancer|June 1, 1979
A phase I study of chlorozotocin (NSC 178248)J S Kovach, C G Moertel, A J Schutt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Cancer Treatment Reports|October 1, 1980
Phase II evaluation of triazinate in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|November 1, 1981
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1979
Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lungR T Eagan, R E Lee, S Frytak, et al.
Pageof 11